AZBio CEO, Joan Koerber-Walker shares highlights from  the 2011 AZBio Awards.  Meet some of this year's award winners.

The AZBio Awards are an Arizona tradition that recognizes the best of the biosciences, showcases our companies, connects our future bioscience leaders to today's. 

The 2011 AZBio Expo brought together innovative and life saving companies from across the state along with leaders from across the industry.   Be sure to check out the highlights and a special spotlight interview where Don Isaacs, VP of Communications at SynCardia Systems, Inc. brings EmpowHER's Shana O'Conner up close and personal with the world's only Total Artificial Heart.  It's why SynCardia was named the 2011 Bioscience Company of the Year.

IBM's David Kerr introduces the crowd at the 2011 AZBio Awards to WATSON and looks at the future of healthcare.

A Global Perspective from executives of Arizona’s Bioscience Companies on why they are in Arizona Panelists Bob Bosserman, CEO, Medelis Janet Spear, Plant Manager, Celgene Joan Koerber-Walker, president & CEO, AZBio (moderator) Dr. Ken Wertman, Scientific Director, Sanofi, Oro Valley Dr. Phil Miller, Ventana Filmed live at the 2011 AZBio Expo

Dr. Michael Birt, director of the Center for Sustainable Health at The Biodesign Institute at Arizona State University shares his thoughts on the future of healthcare in this interview from the floor of the AZBio Expo in 2011.  

EmpowHER reports on the work being done by Arizona's future bioscience leaders as students from across the  state displayed their work and connected with today's bioscience leaders.

Michael Birt, director of the Center for Sustainable Health at the Biodesign Institute at Arizona State University. In Birt’s address, “Sustaining Health: How Do We Prevent and Detect Disease Early Enough to Keep People Healthy … at a Cost We Can Afford?” he calls  for a shift in our health system to reward cost-effective prevention, early detection and intervention. Such a shift and the technology that it would require has the potential to spur growth among bioscience organizations, reduce patient suffering, and lowering health care costs.

IBM’s Watson and future strategies for advancing health. David Kerr, Director, Corporate Strategy, IBM, Armonk, N.Y.